We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Inovio’s COVID-19 Vaccine Trial Placed on Partial Hold
Inovio’s COVID-19 Vaccine Trial Placed on Partial Hold
The FDA has placed a partial clinical hold on Inovio Pharmaceuticals’ planned phase 2/3 trial of its COVID-19 vaccine candidate INO-4800, calling for more information.